Analysts at Citigroup Reiterate their Sell rating for Synergy Pharmaceuticals SGYP (SGYP) with $2.50 Price Objective; Telenav (TNAV)’s Sentiment Is 0.97

September 13, 2017 - By wolcottdaily

Among 4 analysts covering Synergy Pharmaceuticals SGYP (NYSE:SGYP), 3 have Buy rating, 1 Sell and 0 Hold. Therefore 75% are positive. Synergy Pharmaceuticals SGYP has $18 highest and $6 lowest target. $11.67’s average target is 325.91% above currents $2.74 stock price. Synergy Pharmaceuticals SGYP had 4 analyst reports since March 30, 2017 according to SRatingsIntel. Oppenheimer maintained the stock with “Outperform” rating in Friday, September 8 report. Rodman & Renshaw maintained Synergy Pharmaceuticals Inc (NASDAQ:SGYP) on Thursday, March 30 with “Buy” rating. The rating was maintained by BTIG Research on Wednesday, April 12 with “Buy”. The firm has “Sell” rating by Citigroup given on Thursday, April 6.

TeleNav, Inc. is a provider of location platform services. The company has market cap of $277.96 million. The Company’s services consist of its automotive and mobile navigation platform and its advertising delivery platform. It currently has negative earnings. The Firm operates through three divisions: automotive, advertising and mobile navigation.

Since May 26, 2017, it had 2 insider buys, and 0 insider sales for $43,302 activity. On Friday, May 26 the insider JACOB GARY S bought $19,967. 6,500 shares were bought by BRANCACCIO JOHN P, worth $23,335 on Friday, May 26.

Investors sentiment decreased to 1.49 in 2016 Q4. Its down 0.45, from 1.94 in 2016Q3. It fall, as 19 investors sold Synergy Pharmaceuticals Inc shares while 43 reduced holdings. 27 funds opened positions while 47 raised stakes. 113.25 million shares or 15.05% more from 98.44 million shares in 2016Q3 were reported. Moreover, California State Teachers Retirement Systems has 0% invested in Synergy Pharmaceuticals Inc (NASDAQ:SGYP) for 374,144 shares. Kcg holds 73,988 shares. Highbridge Cap Mngmt Lc, a New York-based fund reported 51,839 shares. Savings Bank Of Ny Mellon Corp stated it has 0% in Synergy Pharmaceuticals Inc (NASDAQ:SGYP). Bancshares Of Montreal Can accumulated 582 shares. Grt Ltd Liability Com holds 70,530 shares. Point72 Asia (Hong Kong) Limited holds 0.01% or 1,966 shares in its portfolio. Credit Suisse Ag has 240,918 shares. Modera Wealth Management Lc has invested 0.02% in Synergy Pharmaceuticals Inc (NASDAQ:SGYP). Proshare Advisors Ltd Liability Corporation has invested 0.01% of its portfolio in Synergy Pharmaceuticals Inc (NASDAQ:SGYP). State Board Of Administration Of Florida Retirement System owns 66,421 shares. Mufg Americas reported 3,640 shares. Jpmorgan Chase & reported 0% of its portfolio in Synergy Pharmaceuticals Inc (NASDAQ:SGYP). 18,226 were reported by Sequoia Fincl Advsr Limited Liability Corp. 177,300 are owned by New York State Common Retirement Fund.

About 2.16 million shares traded. Synergy Pharmaceuticals Inc (NYSE:SGYP) has risen 24.44% since September 13, 2016 and is uptrending. It has outperformed by 7.74% the S&P500.

Synergy Pharmaceuticals Inc. is a biopharmaceutical firm focused on the development and commercialization of gastrointestinal therapies. The company has market cap of $616.38 million. The Company’s product candidates include TRULANCE (plecanatide) and dolcanatide. It currently has negative earnings. The Firm is engaged in the discovery, research and development efforts around analogs of uroguanylin for the treatment of GI diseases and disorders.

Since January 1, 0001, it had 1 buy, and 3 sales for $154,179 activity.

About 17,877 shares traded. Telenav Inc (TNAV) has risen 88.62% since September 13, 2016 and is uptrending. It has outperformed by 71.92% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By :